• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性视网膜病变中的固有免疫系统。

The innate immune system in diabetic retinopathy.

机构信息

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, 48105, USA.

Department of Immunology, Cleveland Clinic, Cleveland, OH, 44106, USA.

出版信息

Prog Retin Eye Res. 2021 Sep;84:100940. doi: 10.1016/j.preteyeres.2021.100940. Epub 2021 Jan 8.

DOI:10.1016/j.preteyeres.2021.100940
PMID:33429059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263813/
Abstract

The prevalence of diabetes has been rising steadily in the past half-century, along with the burden of its associated complications, including diabetic retinopathy (DR). DR is currently the most common cause of vision loss in working-age adults in the United States. Historically, DR has been diagnosed and classified clinically based on what is visible by fundoscopy; that is vasculature alterations. However, recent technological advances have confirmed pathology of the neuroretina prior to any detectable vascular changes. These, coupled with molecular studies, and the positive impact of anti-inflammatory therapeutics in DR patients have highlighted the central involvement of the innate immune system. Reminiscent of the systemic impact of diabetes, immune dysregulation has become increasingly identified as a key element of the pathophysiology of DR by interfering with normal homeostatic systems. This review uses the growing body of literature across various model systems to demonstrate the clear involvement of all three pillars of the immune system: immune-competent cells, mediators, and the complement system. It also demonstrates how the relative contribution of each of these requires more extensive analysis, including in human tissues over the continuum of disease progression. Finally, although this review demonstrates how the complex interactions of the immune system pose many more questions than answers, the intimately connected nature of the three pillars of the immune system may also point to possible new targets to reverse or even halt reverse retinopathy.

摘要

在过去的半个世纪中,糖尿病的患病率一直在稳步上升,随之而来的是其相关并发症的负担,包括糖尿病性视网膜病变(DR)。DR 目前是美国工作年龄段成年人视力丧失的最常见原因。从历史上看,DR 的诊断和分类是基于眼底镜检查可见的血管改变来进行的。然而,最近的技术进步已经证实了神经视网膜的病理学变化,而这些变化在任何可检测到的血管变化之前就已经发生了。这些变化,加上分子研究,以及抗炎治疗在 DR 患者中的积极影响,突显了固有免疫系统的核心作用。与糖尿病的全身性影响类似,免疫失调已被越来越多地确定为 DR 病理生理学的关键因素,因为它干扰了正常的体内平衡系统。这篇综述利用各种模型系统中不断增加的文献,证明了免疫系统的所有三个支柱(免疫活性细胞、介质和补体系统)都明显参与其中。它还表明,这些因素中的每一个的相对贡献都需要更广泛的分析,包括在疾病进展的连续过程中对人类组织进行分析。最后,尽管这篇综述表明,免疫系统的复杂相互作用提出的问题多于答案,但免疫系统的三个支柱之间的密切联系也可能指向可能的新靶点,以逆转甚至阻止 DR 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/180c3e98c3b6/nihms-1663909-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/efea151d4197/nihms-1663909-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/8e329c106df8/nihms-1663909-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/c66ecc4017ef/nihms-1663909-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/ddb63ff78dd8/nihms-1663909-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/e7bb3ab329e5/nihms-1663909-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/a3c2c5d129a1/nihms-1663909-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/7df1dfdabbe9/nihms-1663909-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/e9c25be55356/nihms-1663909-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/9ddb219d2b58/nihms-1663909-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/ca8b762592d3/nihms-1663909-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/6d9dcdc982f1/nihms-1663909-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/180c3e98c3b6/nihms-1663909-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/efea151d4197/nihms-1663909-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/8e329c106df8/nihms-1663909-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/c66ecc4017ef/nihms-1663909-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/ddb63ff78dd8/nihms-1663909-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/e7bb3ab329e5/nihms-1663909-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/a3c2c5d129a1/nihms-1663909-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/7df1dfdabbe9/nihms-1663909-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/e9c25be55356/nihms-1663909-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/9ddb219d2b58/nihms-1663909-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/ca8b762592d3/nihms-1663909-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/6d9dcdc982f1/nihms-1663909-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef01/8263813/180c3e98c3b6/nihms-1663909-f0012.jpg

相似文献

1
The innate immune system in diabetic retinopathy.糖尿病性视网膜病变中的固有免疫系统。
Prog Retin Eye Res. 2021 Sep;84:100940. doi: 10.1016/j.preteyeres.2021.100940. Epub 2021 Jan 8.
2
The complement system and diabetic retinopathy.补体系统与糖尿病视网膜病变。
Surv Ophthalmol. 2024 Jul-Aug;69(4):575-584. doi: 10.1016/j.survophthal.2024.02.004. Epub 2024 Feb 23.
3
Diabetic retinopathy and dysregulated innate immunity.糖尿病视网膜病变与先天免疫失调
Vision Res. 2017 Oct;139:39-46. doi: 10.1016/j.visres.2017.04.013. Epub 2017 Jun 2.
4
The Role of Adaptive Immunity in Diabetic Retinopathy.适应性免疫在糖尿病视网膜病变中的作用。
J Clin Med. 2022 Nov 2;11(21):6499. doi: 10.3390/jcm11216499.
5
Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.靶向糖尿病性视网膜病变中的 NLRP3 炎性小体:从发病机制到治疗策略。
Biochem Pharmacol. 2023 Jun;212:115569. doi: 10.1016/j.bcp.2023.115569. Epub 2023 Apr 25.
6
Role of Inflammation in Diabetic Retinopathy.炎症在糖尿病视网膜病变中的作用。
Int J Mol Sci. 2018 Mar 22;19(4):942. doi: 10.3390/ijms19040942.
7
Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.美国不同严重程度的糖尿病视网膜病变与视力相关的功能负担
JAMA Ophthalmol. 2017 Sep 1;135(9):926-932. doi: 10.1001/jamaophthalmol.2017.2553.
8
[Complement system and diabetic retinopathy].[补体系统与糖尿病视网膜病变]
Zhonghua Yan Ke Za Zhi. 2013 Jul;49(7):661-4.
9
Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation.糖尿病的免疫指纹:眼表和视网膜炎症。
Int J Mol Sci. 2023 Jun 6;24(12):9821. doi: 10.3390/ijms24129821.
10
Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.糖尿病性视网膜病变中视网膜神经退行性变:一个新兴概念。
Curr Diab Rep. 2021 Dec 13;21(12):65. doi: 10.1007/s11892-021-01428-x.

引用本文的文献

1
Diabetic retinopathy classification using a multi-attention residual refinement architecture.基于多注意力残差细化架构的糖尿病视网膜病变分类
Sci Rep. 2025 Aug 10;15(1):29266. doi: 10.1038/s41598-025-15269-1.
2
Role of Myeloid-Derived Suppressor Cells (MDSCs), Specifically Monocyte-Derived MDSCs, in Type 2 Diabetes-Related Diabetic Retinopathy.髓源性抑制细胞(MDSCs),特别是单核细胞衍生的MDSCs在2型糖尿病相关糖尿病视网膜病变中的作用。
Diabetes Metab Syndr Obes. 2025 Jul 6;18:2213-2220. doi: 10.2147/DMSO.S527411. eCollection 2025.
3
Targeting mitophagy in diabetic retinopathy: novel insights into SQSTM1/BNIP3L pathway regulated by luteolin.

本文引用的文献

1
Monounsaturated oleic acid modulates autophagy flux and upregulates angiogenic factor production in human retinal pigment epithelial ARPE-19 cells.单不饱和油酸调节人视网膜色素上皮 ARPE-19 细胞的自噬通量并上调血管生成因子的产生。
Life Sci. 2020 Oct 15;259:118391. doi: 10.1016/j.lfs.2020.118391. Epub 2020 Sep 3.
2
The Role of HIF in Immunity and Inflammation.缺氧诱导因子在免疫与炎症中的作用。
Cell Metab. 2020 Oct 6;32(4):524-536. doi: 10.1016/j.cmet.2020.08.002. Epub 2020 Aug 26.
3
Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.
靶向自噬在糖尿病视网膜病变中的作用:木犀草素调控SQSTM1/BNIP3L通路的新见解
Front Pharmacol. 2025 Jun 25;16:1593213. doi: 10.3389/fphar.2025.1593213. eCollection 2025.
4
Prospective evaluation of soluble CD14 as a biomarker following five aflibercept treatments in diabetic macular edema.在糖尿病性黄斑水肿患者接受五次阿柏西普治疗后,将可溶性CD14作为生物标志物的前瞻性评估。
Sci Rep. 2025 May 16;15(1):17080. doi: 10.1038/s41598-025-93472-w.
5
Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration.确定糖尿病视网膜病变的治疗靶点和潜在药物:聚焦于氧化应激和免疫浸润
J Inflamm Res. 2025 Feb 14;18:2205-2227. doi: 10.2147/JIR.S500214. eCollection 2025.
6
Corneal nerve abnormalities in early-stage diabetic retinopathy evaluated by corneal confocal microscopy.通过角膜共焦显微镜评估早期糖尿病视网膜病变中的角膜神经异常。
BMC Ophthalmol. 2025 Jan 30;25(1):51. doi: 10.1186/s12886-025-03880-9.
7
The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications.趋化因子在糖尿病视网膜病变中的作用:病理生理学及临床意义
Int J Mol Sci. 2025 Jan 4;26(1):378. doi: 10.3390/ijms26010378.
8
Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction.巨噬细胞代谢重编程可改善糖尿病引起的微血管功能障碍。
Redox Biol. 2025 Feb;79:103449. doi: 10.1016/j.redox.2024.103449. Epub 2024 Nov 29.
9
Short-Term Culture of Human Hyalocytes Retains Their Initial Phenotype and Displays Their Contraction Abilities.人玻璃体细胞的短期培养保留了其初始表型,并显示出其收缩能力。
Cells. 2024 Nov 6;13(22):1837. doi: 10.3390/cells13221837.
10
The Role of Immune Cells and Signaling Pathways in Diabetic Eye Disease: A Comprehensive Review.免疫细胞和信号通路在糖尿病眼病中的作用:综述
Biomedicines. 2024 Oct 15;12(10):2346. doi: 10.3390/biomedicines12102346.
单细胞转录组分析揭示阿克巴小鼠视网膜中的细胞类型特异性,深入了解糖尿病性视网膜病变的病理生物学。
Diabetologia. 2020 Oct;63(10):2235-2248. doi: 10.1007/s00125-020-05218-0. Epub 2020 Jul 30.
4
The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema.视网膜结构生物标志物在评估玻璃体内注射雷珠单抗和地塞米松玻璃体内植入物治疗糖尿病性黄斑水肿效果中的应用
Diagnostics (Basel). 2020 Jun 17;10(6):413. doi: 10.3390/diagnostics10060413.
5
Diabetic Retinopathy and BDNF: A Review on Its Molecular Basis and Clinical Applications.糖尿病视网膜病变与脑源性神经营养因子:关于其分子基础及临床应用的综述
J Ophthalmol. 2020 May 18;2020:1602739. doi: 10.1155/2020/1602739. eCollection 2020.
6
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.糖尿病视网膜病变和糖尿病黄斑水肿的诊治途径:英国共识工作组。
Eye (Lond). 2020 Jun;34(Suppl 1):1-51. doi: 10.1038/s41433-020-0961-6.
7
Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy.高迁移率族蛋白 B1 信号在糖尿病性视网膜病变炎症过程中的作用。
Cell Signal. 2020 Sep;73:109687. doi: 10.1016/j.cellsig.2020.109687. Epub 2020 Jun 1.
8
The effect of diabetes on vitreous levels of adiponectin and inflammatory cytokines in experimental rat model.糖尿病对实验性大鼠模型玻璃体中脂联素和炎性细胞因子水平的影响。
Adv Clin Exp Med. 2020 Apr;29(4):449-452. doi: 10.17219/acem/115004.
9
The association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with diabetic macular edema.玻璃体内雷珠单抗治疗与糖尿病黄斑水肿患者血清细胞因子浓度的关系。
Mol Vis. 2020 Apr 1;26:246-256. eCollection 2020.
10
Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.通过神经肽 Y 介导增强神经血管微环境治疗糖尿病性视网膜病变。
J Cell Mol Med. 2020 Apr;24(7):3958-3970. doi: 10.1111/jcmm.15016. Epub 2020 Mar 6.